Logo

Jubilant Maps Affymetrix Probes Using Pathways Database

Aug 25, 2004

NEW YORK, Aug. 25 (GenomeWeb News) - Jubilant Biosys of Bangalore, India, said today that it has used PathArt, a database of over 900 signaling and metabolic pathways that are manually curated from literature, to map Affymetrix Probeset IDs.

 

"PathArt ... includes wide coverage on disease-specific pathways such as several cancers, arthritis, Alzheimer's, asthma, multiple sclerosis, Parkinson's, diabetes, and atherosclerosis," Sreenivas Devidas, Jubilant's vice president of business development and strategy said in a statement. "Researchers can map the data generated from Affymetrix chips directly onto pathways."

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.